Search results
Weight loss drugs like Wegovy have taken the country by storm. But who can afford them?
USA TODAY· 6 hours agoSen. Bernie Sanders blasted the Danish drugmaker Novo Nordisk this week for charging U.S. residents...
Drug sales keep beating Wall Street's expectations and boosting some pharma stocks
Quartz· 2 hours agoDrug sales at several pharma companies during the first quarter of the year have exceeded analysts...
Bristol Myers to cut 6% of workforce, trim drug pipeline
BioPharma Dive via Yahoo Finance· 9 hours ago-thirds of the savings is expected to come out of Bristol Myers’ spending on research and...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 1 day agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
Analyst Report: Bristol-Myers Squibb Company
Morningstar Research via Yahoo Finance· 1 hour agoBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where ...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Investor's Business Daily· 2 hours agoMeanwhile, Lilly locked up its acquisition of Point Biopharma, an expert in radioligand treatments...
AI for drug discovery draws a $1 billion launch—and a lot of hope
Fortune via Yahoo Finance· 4 hours agoAny funding round with a B—especially for an early-stage company—represents a big bet and a lot of...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 42 minutes agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
“Little Home Market”: The Connecticut Company Accused of Fueling an Execution Spree
The Intercept· 2 hours agoThe company is registered with Connecticut as a “manufacturer of drugs, cosmetics, and medical...
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth
BioPharma Dive via Yahoo Finance· 5 hours agoAstraZeneca’s London-traded shares rose 6% following the earnings announcement, changing hands at a...